Research progress of methylene blue in septic shock

doi:10.3877/cma.j.issn.2096-1537.2025.04.010

Abstract

Abstract:

Septic shock is one of the most important threats to human life and health. Despite ongoing researches, the morbidity and mortality remain high. As a non-catecholamine-based vasoconstrictor, methylene blue has been shown in many studies to increase mean arterial pressure, reduce the need of catecholamine vasopressors and reduce the mortality of septic shock. However, these findings have not been consistently conclusive. This article reviewed the therapeutic effect of methylene blue in septic shock in this manuscript.

Key words: Septic shock, Methylene blue, Treatment

Zhu Luo, Yichun Sun, Jingyuan Xu. Research progress of methylene blue in septic shock[J]. Chinese Journal of Critical Care & Intensive Care Medicine(Electronic Edition), 2025, 11(04): 397-401.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://icu.cma-cmc.com.cn/EN/10.3877/cma.j.issn.2096-1537.2025.04.010

https://icu.cma-cmc.com.cn/EN/Y2025/V11/I04/397

References 49

1	Bauer M, Gerlach H, Vogelmann T, et al. Mortality in sepsis and septic shock in Europe, North America and Australia between 2009 and 2019- results from a systematic review and meta-analysis [J]. Crit Care, 2020, 24(1): 239.
2	Singer M, Deutschman CS, Seymour CW, et al. The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3) [J]. JAMA, 2016, 315(8): 801-810.
3	Evans L, Rhodes A, Alhazzani W, et al. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 [J]. Intensive Care Med, 2021, 47(11): 1181-1247.
4	Cecconi M, Evans L, Levy M, et al. Sepsis and septic shock [J]. Lancet, 2018, 392 (10141): 75-87.
5	Dünser MW, Hasibeder WR. Sympathetic overstimulation during critical illness: adverse effects of adrenergic stress [J]. J Intensive Care Med, 2009, 24(5): 293-316.
6	Daff S. NO synthase: structures and mechanisms [J]. Nitric Oxide, 2010, 23(1): 1-11.
7	Tatsumi R, Wuollet AL, Tabata K, et al. A role for calcium-calmodulin in regulating nitric oxide production during skeletal muscle satellite cell activation [J]. Am J Physiol Cell Physiol, 2009, 296(4): C922-C929.
8	Salemme E, Diano S, Maharajan P, et al. Nitric oxide, a neuronal messenger. Its role in the hippocampus neuronal plasticity [J]. Riv Biol, 1996, 89(1): 87-107.
9	Izumi Y, Clifford DB, Zorumski CF. Inhibition of long-term potentiation by NMDA-mediated nitric oxide release [J]. Science, 1992, 257(5074): 1273-1276.
10	Handy RL, Wallace P, Moore PK. Inhibition of nitric oxide synthase by isothioureas: cardiovascular and antinociceptive effects [J]. Pharmacol Biochem Behav, 1996, 55(2): 179-184.
11	Togashi H, Sakuma I, Yoshioka M, et al. A central nervous system action of nitric oxide in blood pressure regulation [J]. J Pharmacol Exp Ther, 1992, 262(1): 343-347.
12	Shaul PW. Regulation of endothelial nitric oxide synthase: location, location, location [J]. Annu Rev Physiol, 2002, 64: 749-774.
13	Zeiher AM, Fisslthaler B, Schray-Utz B, et al. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells [J]. Circ Res, 1995, 76(6): 980-986.
14	Alheid U, Frölich JC, Förstermann U. Endothelium-derived relaxing factor from cultured human endothelial cells inhibits aggregation of human platelets [J]. Thromb Res, 1987, 47(5): 561-571.
15	Kurihara N, Alfie ME, Sigmon DH, et al. Role of nNOS in blood pressure regulation in eNOS null mutant mice [J]. Hypertension, 1998, 32(5): 856-861.
16	Nathan CF, Hibbs JB Jr. Role of nitric oxide synthesis in macrophage antimicrobial activity [J]. Curr Opin Immunol, 1991, 3(1): 65-70.
17	MacNaul KL, Hutchinson NI. Differential expression of iNOS and cNOS mRNA in human vascular smooth muscle cells and endothelial cells under normal and inflammatory conditions [J]. Biochem Biophys Res Commun, 1993, 196(3): 1330-1334.
18	Jang DH, Nelson LS, Hoffman RS. Methylene blue for distributive shock: a potential new use of an old antidote [J]. J Med Toxicol, 2013, 9(3): 242-249.
19	Lambden S, Creagh-Brown BC, Hunt J, et al. Definitions and pathophysiology of vasoplegic shock [J]. Crit Care, 2018, 22(1): 174.
20	Carvajal JA, Germain AM, Huidobro-Toro JP, et al. Molecular mechanism of cGMP-mediated smooth muscle relaxation [J]. J Cell Physiol, 2000, 184(3): 409-420.
21	Cobb JP, Danner RL. Nitric oxide and septic shock [J]. JAMA, 1996, 275 (15): 1192-1196.
22	Forstermann U, Sessa W. Nitric oxide synthases: regulation and function [J]. Eur Heart J, 2012, 33(7): 829-837.
23	Cauwels A. Nitric oxide in shock [J]. Kidney Int, 2007, 72: 557-565.
24	Nathan C, Xie QW. Nitric oxide synthases: roles, tolls, and controls [J]. Cell, 1994, 78: 915-918.
25	de Belder AJ, Radomski MW, Why HJ, et al. Nitric oxide synthase activities in human myocardium [J]. Lancet, 1993, 341: 84-85.
26	Lowenstein CJ, Dinerman JL, Snyder SH. Nitric oxide: a physiologic messenger [J]. Ann Intern Med, 1994, 120: 227-237.
27	Vallance P, Benjamin N, Collier J. The effect of endothelium-derived nitric oxide on ex vivo whole blood platelet aggregation in man [J]. Eur J Clin Pharmacol, 1992, 42(1): 37-41.
28	Evgenov OV, Bjertnaes LJ. Administration of methylene blue in human septic shock: renaissance of an old drug? [J]. Crit Care Med, 2003, 31(5): 1601-1602.
29	Tchen S, Sullivan JB. Clinical utility of midodrine and methylene blue as catecholamine-sparing agents in intensive care unit patients with shock [J]. J Crit Care, 2020, 57: 148-156.
30	Ibarra-Estrada M, Kattan E, Aguilera-González P, et al. Early adjunctive methylene blue in patients with septic shock: a randomized controlled trial [J]. Crit Care, 2023, 27(1): 110.
31	Belletti A, Musu M, Silvetti S, et al. Non-Adrenergic Vasopressors in Patients with or at Risk for Vasodilatory Shock. A systematic review and Meta-analysis of randomized trials [J]. PLoS One, 2015, 10(11): e0142605.
32	Zhao CC, Zhai YJ, Hu ZJ, et al. Efficacy and safety of methylene blue in patients with vasodilatory shock: a systematic review and meta-analysis [J]. Front Med (Lausanne), 2022, 9: 950596.
33	Ballarin RS, Lazzarin T, Zornoff L, et al. Methylene blue in sepsis and septic shock: a systematic review and meta-analysis [J]. Front Med (Lausanne), 2024, 11: 1366062.
34	Fernando SM, Tran A, Soliman K, et al. Methylene blue in septic shock: a systematic review and Meta-analysis [J]. Crit Care Explor, 2024, 6(7): e1110.
35	Pluta MP, Putowski Z, Czempik PF, et al. Successful use of methylene blue in catecholamine-resistant septic shock: a case report and short literature review [J]. Int J Mol Sci, 2023, 24(13): 10772.
36	Memis D, Karamanlioglu B, Yuksel M, et al. The influence of methylene blue infusion on cytokine levels during severe sepsis [J]. Anaesth Intensive Care, 2002, 30(6): 755-762.
37	Kirov MY, Evgenov OV, Evgenov NV, et al. Infusion of methylene blue in human septic shock: a pilot, randomized, controlled study[J]. Crit Care Med, 2001, 29(10): 1860-1867.
38	Weingartner R, Oliveira E, Oliveira ES, et al. Blockade of the action of nitric oxide in human septic shock increases systemic vascular resistance and has detrimental effects on pulmonary function after a short infusion of methylene blue [J]. Braz J Med BiolRes, 1999, 32(12): 1505-1513.
39	Donati A, Conti G, Loggi S, et al. Does methylene blue administration to septic shock patients affect vascular permeability and blood volume? [J]. Crit Care Med, 2002, 30(10): 2271-2277.
40	Brown G, Frankl D, Phang T. Continuous infusion of methylene blue for septic shock [J]. Postgrad Med J, 1996, 72(852): 612-614.
41	Park BK, Shim TS, Lim CM, et al. The effects of methylene blue on hemodynamic parameters and cytokine levels in refractory septic shock [J]. Korean J Intern Med, 2005, 20(2): 123-128.
42	Andresen M, Dougnac A, Diaz O, et al. Use of methylene blue in patients with refractory septic shock: impact on hemodynamics and gas exchange [J]. J Crit Care, 1998, 13(4): 164-168.
43	Gachot B, Bedos JP, Veber B, et al. Short-term effects of methylene blue on hemodynamics and gas exchange in humans with septic shock [J]. Intensive Care Med, 1995, 21(12): 1027-1031.
44	Dumbarton TC, Minor S, Yeung CK, et al. Prolonged methylene blue infusion in refractory septicshock: a case report [J]. Can J Anesth, 2011, 58(4): 401-405.
45	Fernandes D, da Silva-Santos JE, Duma D, et al. Nitric oxide dependent reduction in soluble guanylate cyclase functionality accounts for early lipopolysaccharide-induced changes in vascular reactivity [J]. Mol Pharmacol, 2006, 69(3): 983-990.
46	Puntillo F, Giglio M, Pasqualucci A, et al. Vasopressor-sparing action of methylene blue in severe sepsis and shock: a narrative review [J]. Adv Ther, 2020, 37(9): 3692-3706.
47	薛晋芳, 娄熙冉, 陈国兵. 亚甲蓝治疗脓毒症及脓毒性休克的研究进展 [J]. 中华危重病急救医学, 2021, 33(11): 1384-1387.
48	Juffermans NP, Vervloet MG, Daemen-Gubbels CR, et al. A dose-finding study of methylene blue to inhibit nitric oxide actions in the hemodynamics of human septic shock [J]. Nitric Oxide, 2010, 22(4): 275-280.
49	Rutledge C, Brown B, Benner K, et al. A novel use of methylene blue in the pediatric ICU [J]. Pediatrics, 2015, 136(4): e1030-e1034.

[1]	Xiaopei Dong, Yang Yuan, Jianbin Li, Hua Song, Fan Li, Yi Hao, Li Bian, Tao Wang, Zefei Jiang, Shaohua Zhang. Prognostic analysis of first-line therapy in hormone receptor-positive/HER-2-negative breast cancer patients with bone-only metastases [J]. Chinese Journal of Breast Disease(Electronic Edition), 2026, 20(01): 25-33.
[2]	Rui Jiao, Gang Xu, Huibin Lian, Zhimin Yin, Hui Han, Jie Zhou. Discussion on the treatment of gluteal muscle and skin necrosis caused by arterial embolization for massive hemorrhage due to pelvic fracture [J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2026, 21(01): 7-11.
[3]	Simin Huang, Liangqi Cao. Precision diagnosis and treatment of hepatobiliary and pancreatic diseases driven by endoscopic techniques [J]. Chinese Archives of General Surgery(Electronic Edition), 2026, 20(01): 1-5.
[4]	Xiaosi Hu, Huichun Liu. Functional preservation of Oddi sphincter in minimally invasive treatment for choledocholithiasis [J]. Chinese Archives of General Surgery(Electronic Edition), 2026, 20(01): 6-9.
[5]	Guangxin Li, Huijuan Quan, Zhijuan Gao, Liang Li, Xiaojun Wang, Yuqing Cao. Comparison of the clinical effects of emergency laparoscopic resection and stent placement with delayed resection in the treatment of obstructive colorectal cancer [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(02): 142-145.
[6]	Shuai Zhang, Dexiang Liao, Qiangqiang Zhang, Weidong Jin, Zhiyong Zhang, Dandan Ma, Tao Fu. The impact of the establishment of the abdominal pain center on the efficiency of treating patients with acute abdominal conditions [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(01): 71-74.
[7]	Long Wang, Haiqiao Zhang, Yong Huang, Jiaxuan Li, Yuhao Zhai, Jie Yin, Jun Zhang. Two cases of gastric desmoid-type fibroma with literature review [J]. Chinese Journal of Operative Procedures of General Surgery(Electronic Edition), 2026, 20(01): 96-98.
[8]	Xiaobo Ding, Jie Chen, Yanbo Wang. Progress in the application of artificial intelligence in the diagnosis and treatment of urinary calculi [J]. Chinese Journal of Endourology(Electronic Edition), 2026, 20(01): 15-21.
[9]	Jianxiong Li, Cheng Yang, Kang He, Kangyi Xue, Wenbin Guo, Mingkun Chen, Cundong Liu. Varicocele with thrombosis: a report of two cases [J]. Chinese Journal of Endourology(Electronic Edition), 2026, 20(01): 114-116.
[10]	Hong Wang, Guoqiang Dong, Xingzhou Zhang, Weijun Liu, Nan Zhang. Short-term efficacy comparison between robot-assisted and laparoscopic surgery for complex abdominal wall hernias [J]. Chinese Journal of Hernia and Abdominal Wall Surgery(Electronic Edition), 2026, 20(01): 68-73.
[11]	Jianping Liu, Cankai Yao. Strategy selection and timing of conversion therapy for hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(01): 16-20.
[12]	Long Zhang, Wei Xu, Shanke Sun, Wenzhu Li, Junda Li, Yongquan Chi, Jinhua Song, Xuehao Wang, Feng Cheng, Jianhua Rao. Efficacy and safety of drug-eluting beads transarterial chemoembolization in conversion therapy for massive hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(01): 28-35.
[13]	Wenqing Zhong, Bing Han. A Nomogram model based on preoperative CT imaging data for predicting survival of patients with hepatocellular carcinoma [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(01): 53-58.
[14]	Hongnian Shen, Hanxiao Lu, Shuo Zhang, Donglin Jiang, Wen Xiang, Jie Xiang, Jun Yang. Clinical diagnosis and treatment of nonalcoholic fatty liver disease-associated hepatocellular carcinoma: a single-center analysis [J]. Chinese Journal of Hepatic Surgery(Electronic Edition), 2026, 15(01): 95-100.
[15]	Juanjuan Ci, Juncheng Wu, Qinqin Zhu. Construction and verification of a nomogram of rebleeding risk in patients with liver cirrhosis complicated with esophageal and gastric varices rupture and bleeding after endoscopic treatment [J]. Chinese Journal of Digestion and Medical Imageology(Electronic Edition), 2026, 16(01): 47-52.

Please choose a citation manager

Content to export